Trial intelligence / Profile preview

PIRAD: Pharmacodynamic Interactions of Remifentanil and Dexmedetomidine

NCT03143972Phase 4Completed

Sponsor
University Medical Center Groningen
Start
Jun 2017
Primary completion
Feb 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine, remifentanil in Anesthesia, sponsored by University Medical Center Groningen. Started Jun 2017; status: completed.

02

Drugs

dexmedetomidineremifentanil
03

Conditions

Anesthesia

Beyond the preview

Go deeper on NCT03143972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03143972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call